Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07341399 · ClinicalTrials.gov registry record · NA
Essential Amino Acid Supplementation in Adult Spinal Deformity Patients
A NA study, sponsored by University of Arkansas.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07341399: Clinical Trial NA study, sponsored by University of Arkansas.
NCT07341399 is a NA study that has not yet begun recruiting, run by University of Arkansas. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07341399, a NA study, has not yet begun recruiting, sponsored by University of Arkansas.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This will be a randomized double-blind placebo controlled clinical trial to determine if supplementing with essential amino acids (EAAs) for two weeks prior to, and 3 months after corrective spinal surgery in adults with spinal deformity can stimulate greater muscle protein turnover and whole-body protein balance, and enhance recovery after surgery when compared to a calorie matched placebo.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Essential Amino Acid Supplement by Amino Co
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2027-05-15 |
| Phase | NA |
What is known before NCT07341399 opens enrollment
NCT07341399 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07341399 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07341399 about?
NCT07341399 is a clinical study titled "Essential Amino Acid Supplementation in Adult Spinal Deformity Patients". This will be a randomized double-blind placebo controlled clinical trial to determine if supplementing with essential amino acids (EAAs) for two weeks prior to, and 3 months after corrective spinal surgery in adults with spinal deformity can stimulate greater muscle protein turnover and whole-body p...
What is the current status of trial NCT07341399?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-07-01. Estimated completion is 2027-05-15.
What interventions are being tested in trial NCT07341399?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Essential Amino Acid Supplement by Amino Co (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07341399?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07341399's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI